🇺🇸 FDA
Pipeline program

Ketamine Hydrochloride

STU 092017-068

Approved small_molecule completed

Quick answer

Ketamine Hydrochloride for Hemorrhage is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Hemorrhage
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials